Mylan Prepares For US Trastuzumab Entry

Plans To Introduce Herceptin Rival ‘In A Couple Of Weeks’

 
• By Aidan Fry
  
Calendar
Mylan is preparing for the imminent launch of its Ogivri trastuzumab biosimilar in the US • Source: Shutterstock

More from Biosimilars

More from Products